about
Closed-loop insulin delivery for treatment of type 1 diabetesAbstracts from ATTD 20147th International Conference on AdvancedTechnologies & Treatments for DiabetesVienna, Austria, February 5–8, 2014Continuous glucose monitoring: current use and future directionsFeasibility study of a bio-inspired artificial pancreas in adults with type 1 diabetes.Design of the health monitoring system for the artificial pancreas: low glucose prediction moduleAnalysis of glucose responses to automated insulin suspension with sensor-augmented pump therapyQuest for the artificial pancreas: combining technology with treatmentThe use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes.Clinical evaluation of a noninvasive alarm system for nocturnal hypoglycemiaA randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension.Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes.Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.New-generation diabetes management: glucose sensor-augmented insulin pump therapy.Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing KetosisHypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home StudyClosed-loop insulin delivery in type 1 diabetes.Clinically relevant hypoglycemia prediction metrics for event mitigationOutpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemiaOvernight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studiesHypoglycemia-associated autonomic failure in healthy humans: comparison of two vs three periods of hypoglycemia on hypoglycemia-induced counterregulatory and symptom response 5 days later.Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.Closed-loop insulin delivery: from bench to clinical practice."Turn it off!": diabetes device alarm fatigue considerations for the present and the future.Insight into hypoglycemia in pediatric type 1 diabetes mellitusInnovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system).Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.Context-dependent memory following recurrent hypoglycaemia in non-diabetic rats is mediated via glucocorticoid signalling in the dorsal hippocampus.ISPAD Guidelines. Managing diabetes in preschool children.Clinical equipoise: an argument for expedited approval of the first small step toward an autonomous artificial pancreas.Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.Assessment and management of hypoglycemia in children and adolescents with diabetes
P2860
Q27008127-4C2CB6C8-16D2-49AB-9778-A176429078DEQ28659224-1F7323D6-2440-4238-BD56-D0A259AD1B44Q30354773-AC4581DA-2AD3-4D72-A49A-05EEA6297F7BQ30410965-732C975F-52D5-428F-8D0C-D74B8FF19242Q30416619-0F34A578-D967-4E93-B74E-BD0E2440CC3EQ30452860-CAF503B3-19A6-430C-85BF-853A9D3C939AQ33349521-6F9B7A33-D11F-41B4-92AD-1BC4B77A921FQ33439009-66980885-78A8-439B-8612-41BC8579712BQ33674494-8B8903CC-02F5-47F4-A669-27FC1F98B460Q33793799-49AA1DFD-8E9D-45FE-97B5-88D0E836160EQ33804556-31093B6E-A9FE-4D32-9B3C-0563B2B50745Q33804568-6E178772-EF3F-4E82-9F21-4DC7F04D391CQ34213303-60181A4B-0FA5-437D-B86C-77604DF100B8Q34420010-70A85831-5137-407B-8F4F-1CB474D47BA2Q35224968-98588C80-F4A9-4619-A4BE-ACD421E8A902Q35608603-6B2F839F-9C48-423A-8017-26EFB4BF7366Q35769485-1F571052-4625-4C0D-BF3B-A1E5C6DEF01FQ35927924-C236F8D8-9006-4054-A1D7-014980BF3048Q35954124-B4187992-05CB-4355-A65C-B6D54DAD6FC8Q36131604-23784C77-B971-4D9D-B2E0-F924BDC01BCFQ37102080-BB011A39-7D02-4071-8393-8D5DDAFD1F29Q37404440-8EBD64F0-1CF0-4839-B746-F50312917A91Q37554705-143EA3F5-6A54-4FD5-8EA1-15452B3281FCQ37597019-9CC33DCB-CB09-4EA5-B4F1-754083BFD1B2Q37781158-54C8BB7D-034F-4F6A-A7D5-6DFFBEFA637CQ37846089-A15E565B-B494-4460-AE61-68DBBF5EEFF0Q39403563-AFE59D50-5594-42D5-AE22-FE50E34B5229Q42275327-EADCDB21-E610-4CDC-91ED-51E4C6253167Q42938617-D7583E90-1A9B-4D4F-A987-1570B9924CFEQ46726172-E4DF3193-3168-4E7C-BDF4-3C7BD87E6360Q47126005-390384FE-36CF-4358-954E-E726DA9F3CCAQ47774594-B578FB92-4E7C-4928-96A6-E1ADCD1D3BDDQ48399179-E964415B-5200-4622-82BC-1BD17B18462FQ48640080-DAF6D486-C9A4-41B5-96E5-24B7D5A22F55Q58811105-331B63A3-07EE-4796-9FB7-1C10D4768612
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Duration of nocturnal hypoglycemia before seizures.
@en
type
label
Duration of nocturnal hypoglycemia before seizures.
@en
prefLabel
Duration of nocturnal hypoglycemia before seizures.
@en
P2093
P2860
P356
P1433
P1476
Duration of nocturnal hypoglycemia before seizures.
@en
P2093
Bruce Buckingham
Darrell M Wilson
Fergus Cameron
Kevin Kaiserman
Ragnar Hanas
Todd Lecher
P2860
P304
P356
10.2337/DC08-0863
P407
P577
2008-08-11T00:00:00Z